Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2003
02/18/2003US6521225 AAV vectors
02/18/2003CA2283751C Frozen food product containing anti-freeze peptides
02/18/2003CA2080213C Diagnostic reagent for hepatitis c
02/18/2003CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19
02/18/2003CA2067031C Dna coding for human cell surface antigen
02/18/2003CA2064331C Vascular endothelial cell growth factor c subunit
02/18/2003CA2061382C Method for producing cysteine-free peptide
02/17/2003CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
02/15/2003CA2392305A1 Adrenic acid receptor and uses thereof
02/14/2003WO2002014506A1 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm
02/14/2003CA2419460A1 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm
02/13/2003WO2003012448A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs
02/13/2003WO2003012441A1 Method for detecting modulators of notch signalling
02/13/2003WO2003012395A2 Early detection of mycobacterial disease using peptides
02/13/2003WO2003012394A2 Androgen receptor knock-out transgenic animals
02/13/2003WO2003012148A2 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120
02/13/2003WO2003012141A1 Method of screening alzheimer’s disease-associated gene
02/13/2003WO2003012133A2 Isp-1 and ctb-1 genes and uses thereof
02/13/2003WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization
02/13/2003WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer
02/13/2003WO2003012121A2 Collagen xxii, a novel human collagen and uses thereof
02/13/2003WO2003012120A2 Lp354 mammalian secreted protein
02/13/2003WO2003012113A2 Inducible expression systems employing ppar transcriptional activators
02/13/2003WO2003012112A1 Methylation resistant vectors
02/13/2003WO2003012111A2 Conjugates for the modulation of immune responses
02/13/2003WO2003012107A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
02/13/2003WO2003012106A2 Regulating nucleic acid for expressing a polynucleotide of interest specifically in the endothelium of a plant seed and uses thereof
02/13/2003WO2003012105A2 Vegf isoform
02/13/2003WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof
02/13/2003WO2003012103A2 Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses
02/13/2003WO2003012102A2 Nucleic acids coding for novel hect domain proteins, their diagnostic and therapeutic uses
02/13/2003WO2003012101A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production
02/13/2003WO2003012096A2 Plant stress regulated genes
02/13/2003WO2003012093A2 Regulator of calcineurin
02/13/2003WO2003012089A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
02/13/2003WO2003012086A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/13/2003WO2003012085A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/13/2003WO2003012075A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation
02/13/2003WO2003012072A2 Monoclonal antibodies to activated erbb family members and methods of use thereof
02/13/2003WO2003012070A2 Gene associated with bone disorders
02/13/2003WO2003012069A2 Compositions and methods for generating chimeric heteromultimers
02/13/2003WO2003012064A2 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/13/2003WO2003012063A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
02/13/2003WO2003012062A2 Animal model with disrupted fgf14 gene
02/13/2003WO2003012053A2 Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis
02/13/2003WO2003012048A2 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof
02/13/2003WO2003012047A2 Isolation of membrane bound ligand-specific complexes
02/13/2003WO2003012045A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
02/13/2003WO2003012044A2 Hagfish cathelin-associated antimicrobial peptides and genes
02/13/2003WO2003012041A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
02/13/2003WO2003012037A2 Tnf receptor 2 related protein variant
02/13/2003WO2003011908A2 Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof
02/13/2003WO2003011907A2 Receptor, the use thereof, and mouse antibodies
02/13/2003WO2003011906A2 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
02/13/2003WO2003011905A1 Novel serine protease
02/13/2003WO2003011904A1 C-terminal region protein of the human nucleolar phosphoprotein hnopp 140 that specifically interact with doxorubicin and the gene thereof
02/13/2003WO2003011903A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera
02/13/2003WO2003011902A1 Identification of specific tumour antigens by selection of cdna libraries with sera
02/13/2003WO2003011901A1 Methods for identifying substances interacting with pleckstrin homology domains, and proteins containing mutated pleckstrin homology domains
02/13/2003WO2003011899A2 Antigenic polypeptides
02/13/2003WO2003011898A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
02/13/2003WO2003011897A1 Modulation of heregulin and her3 interaction
02/13/2003WO2003011895A2 Compositions and methods for modulation of immune responses
02/13/2003WO2003011894A1 The production of soluble keratin derivatives
02/13/2003WO2003011893A2 Immunologically significant herpes simplex virus antigens and methods for using same
02/13/2003WO2003011892A2 Glp-1 exendin-4 peptide analogs and uses thereof
02/13/2003WO2003011823A2 Crfr1 selective ligands
02/13/2003WO2003011334A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
02/13/2003WO2003011332A1 Methods relating to improved polyepitope vaccination strategies
02/13/2003WO2003011331A2 Materials and methods relating to improved vaccination strategies
02/13/2003WO2003011326A1 Use of long pentraxin ptx3 for treating female infertility
02/13/2003WO2003011324A1 Agonists and antagonists of moxifin for the treatment of metabolic disorders
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
02/13/2003WO2003011209A2 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes
02/13/2003WO2003011118A2 Human zona pellucida proteins and methods of their use in diagnosing male infertility
02/13/2003WO2003011015A2 Methods for improving seed and grain characteristics
02/13/2003WO2002096947A8 The lectin-like domain of thrombomodulin and its therapeutic use
02/13/2003WO2002088352A3 Schwann cell specific enhancer and methods of use thereof
02/13/2003WO2002083728A3 Splice variant
02/13/2003WO2002080849A3 Chemotherapeutic induction of egr-1 promoter activity
02/13/2003WO2002079380A3 Disruptions in gaba receptor rh02 subunit, methods adn uses thereof
02/13/2003WO2002070648A3 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
02/13/2003WO2002069907A3 Anti-neovasculature preparations for cancer
02/13/2003WO2002069232A3 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
02/13/2003WO2002066514A3 Artificial fusion proteins with reduced immunogenicity
02/13/2003WO2002066067A3 Albumin-based drug delivery system and antimicrobial peptides
02/13/2003WO2002062849A3 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof
02/13/2003WO2002062296A3 Methods and compositions useful for stimulating an immune response
02/13/2003WO2002059261A3 Inhibition of restenosis using a dna-coated stent
02/13/2003WO2002055556A3 Regulation of human voltage gated potassium channel protein kv2.2
02/13/2003WO2002053741A8 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
02/13/2003WO2002053723B1 Degradation and detection of tse infectivity
02/13/2003WO2002051434A3 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
02/13/2003WO2002047719A3 Survical promoting ncam binding and ncam ligand biding compounds
02/13/2003WO2002044330A3 Crystal structure of rotavirus nsp4 peptide
02/13/2003WO2002042118A3 Oil maintenance indicator
02/13/2003WO2002041691A3 Transgenic or recombinant non-human mammals and their uses in screening psycho-active medicines
02/13/2003WO2002040688A9 Maize yellow stripe1 and related genes
02/13/2003WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
1 ... 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 ... 2916